Moleculin Biotech Revenue

Pharmaceutical Manufacturing • Houston, Texas, United States • 21-50 Employees

Moleculin Biotech revenue & valuation

Annual revenue	$8,019,561
Revenue per employee	$365,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$25,700,000
Total funding	$93,000,000

Key Contacts at Moleculin Biotech

Erikson Wasyl

Director Clinical Operations

Loe L

Director Of Research Development

Company overview

Headquarters	5300 Memorial Dr, Suite 950, Houston, Texas 77007, US
Phone number	+17133005160
Website	moleculin.com
NAICS	3254
SIC	283
Founded	2006
Employees	21-50
Socials

Moleculin Biotech Email Formats

Moleculin Biotech uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@moleculin.com), used 66.7% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@moleculin.com	66.7%
{first name}{last name}	johndoe@moleculin.com	33.3%

About Moleculin Biotech

Moleculin Biotech, Inc. (NASDAQ: MBRX) is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The Company’s lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity. Annamycin is currently in development for the treatment of soft tissue sarcoma (STS) lung metastases and relapsed or refractory acute myeloid leukemia (AML). Moleculin is also engaged in the development of a portfolio of antimetabolites, including WP1122 for the potential treatment of COVID-19 and other viruses, as well as cancer indications including brain tumors, pancreatic and other cancers. Additionally, the Company is developing WP1066, an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers, and WP1220, an analog to WP1066, for the topical treatment of cutaneous T-cell lymphoma.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Vice President

Employees by Department

Moleculin Biotech has 7 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Moleculin Biotech's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2021-03-03	14	$67,800,000
2024-01-20	14	$4,500,000
2024-09-16	14	$5,500,000
2025-03-13	14	$5,800,000
2025-03-25	14	$3,500,000
2025-07-20	14	$5,900,000

Funding Insights

$93,000,000

Total funding amount

$5,900,000

Most recent funding amount

Number of funding rounds

Moleculin Biotech Tech Stack

Discover the technologies and tools that power Moleculin Biotech's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

Slick

JavaScript libraries

Vimeo

Video players

Matomo Analytics

Analytics

Microsoft 365

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

Tippy.js

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Divi

Page builders

Google Analytics

Analytics

Frequently asked questions

Moleculin Biotech is located in Houston, Texas, US.

You can reach Moleculin Biotech at +17133005160.

Moleculin Biotech generates an estimated annual revenue of $8,019,561. This revenue figure reflects the company's market position and business performance in its industry.

Moleculin Biotech has an estimated valuation of $25,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Moleculin Biotech was founded in 2006, making it 20 years old. The company has established itself as a significant player in its industry over this time.

Moleculin Biotech has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Moleculin Biotech has raised a total of $93,000,000 across 6 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Moleculin Biotech

Erikson Wasyl

Director Clinical Operations

Loe L

Director Of Research Development

4.8

40,000 users